Cite
HARVARD Citation
Hu, K. et al. (2021). Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway. Acta biochimica et biophysica Sinica. pp. 575-583. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hu, K. et al. (2021). Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway. Acta biochimica et biophysica Sinica. pp. 575-583. [Online].